Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

CNS Pharmaceuticals, Inc. (CNSP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.9950-0.0750 (-7.01%)
At close: 04:00PM EST
0.9500 -0.05 (-4.52%)
After hours: 06:53PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.0700
Open1.0500
Bid0.9800 x 900
Ask0.9600 x 1000
Day's Range0.9801 - 1.0600
52 Week Range0.9800 - 4.4600
Volume168,774
Avg. Volume207,371
Market Cap25.232M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.6370
Earnings DateMay 14, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.25
  • PR Newswire

    CNS Pharmaceuticals Receives Approval from Switzerland Ethics Committee for its Potentially Pivotal Study of Berubicin for the Treatment of Glioblastoma Multiforme (GBM)

    CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced it has received approval from swissethics, the umbrella organization of the cantonal Ethics Committees (EC) in Switzerland, for the Company's potentially pivotal study of Berubicin for the treatment of recurrent glioblastoma multiforme (GBM), one of the most ag

  • PR Newswire

    CNS Pharmaceuticals to Present at the Virtual Investor Roundtable Event

    CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that John Climaco, Chief Executive Officer and Sandra L. Silberman, MD, PhD Chief Medical Officer will participate in the Virtual Investor Roundtable Event on Thursday, November 18, 2021 at 9:00 AM ET.

  • ACCESSWIRE

    JTC Team to Host Virtual Investor Roundtable Event on November 16th, 17th, and 18th

    \- Access the event and schedule of presenting companies at virtualinvestorco.com - \- Live video webcast roundtable discussions with members of Management and Thought Leaders across participating companies -PITTSTOWN, NJ / ACCESSWIRE / November 4, 2021 / November 4, 2021 - JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today announced it will host the Virtual Investor Roundtable Event November 16-18, 2021.

Advertisement
Advertisement